Last update 20 Mar 2025

Cefepime Hydrochloride/Enmetazobactam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AAI 101/cefepime, Cefepime/enmetazobactam, EMT/FEP
+ [4]
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
RegulationQualified Infectious Disease Product (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC11H14N4O5S
InChIKeyHFZITXBUTWITPT-YWVKMMECSA-N
CAS Registry1001404-83-6
View All Structures (2)

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bacteremia
European Union
21 Mar 2024
Bacteremia
Liechtenstein
21 Mar 2024
Bacteremia
Norway
21 Mar 2024
Bacteremia
Iceland
21 Mar 2024
Complicated urinary tract infection
Liechtenstein
21 Mar 2024
Complicated urinary tract infection
European Union
21 Mar 2024
Complicated urinary tract infection
Norway
21 Mar 2024
Complicated urinary tract infection
Iceland
21 Mar 2024
Hospital-acquired pneumonia
Iceland
21 Mar 2024
Hospital-acquired pneumonia
European Union
21 Mar 2024
Hospital-acquired pneumonia
Norway
21 Mar 2024
Hospital-acquired pneumonia
Liechtenstein
21 Mar 2024
Pneumonia, Ventilator-Associated
Norway
21 Mar 2024
Pneumonia, Ventilator-Associated
Liechtenstein
21 Mar 2024
Pneumonia, Ventilator-Associated
European Union
21 Mar 2024
Pneumonia, Ventilator-Associated
Iceland
21 Mar 2024
Pyelonephritis
Norway
21 Mar 2024
Pyelonephritis
Liechtenstein
21 Mar 2024
Pyelonephritis
European Union
21 Mar 2024
Pyelonephritis
Iceland
21 Mar 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Complicated urinary tract infectionDiscovery
United States
22 Feb 2024
Acute pyelonephritisDiscovery
Slovakia
05 Sep 2017
Acute pyelonephritisDiscovery
Ukraine
05 Sep 2017
Acute pyelonephritisDiscovery
Hungary
05 Sep 2017
Acute pyelonephritisDiscovery
Czechia
05 Sep 2017
Acute pyelonephritisDiscovery
Poland
05 Sep 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,034
(qbxfffwfje) = rcwmyxmlgp xkaqvbngjn (tjjjzpjsfj )
Superior
22 Feb 2024
(qbxfffwfje) = turyqjxkhk xkaqvbngjn (tjjjzpjsfj )
Phase 3
1,041
(tdefrpqpcp) = rikpcrutbf hdizkflqhf (ehnpjfcgid )
Superior
04 Oct 2022
Tazobactam+Piperacillin
(tdefrpqpcp) = aoerxqxhvj hdizkflqhf (ehnpjfcgid )
Not Applicable
72
(gbazwxrwwt) = njhfciouzw yvrzcsqomz (fbveppohuz )
-
20 May 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free